Assessment of Atrial Late Potentials in Patients with Hypercholesterolemia, to Investigate the Preventive Effect of Pitavastatin on Atrial Fibrillation.

Trial Profile

Assessment of Atrial Late Potentials in Patients with Hypercholesterolemia, to Investigate the Preventive Effect of Pitavastatin on Atrial Fibrillation.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Pitavastatin (Primary) ; Ezetimibe; Fenofibrate
  • Indications Atrial fibrillation; Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Acronyms ALPINA
  • Most Recent Events

    • 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
    • 08 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top